More Americans Than Ever Are Taking Weight-Loss Drugs

The number of U.S. adults utilizing obesity medication has nearly quadrupled over the last two years. Meanwhile, a month-long trial of GLP-1 weight loss patches showed reduced cravings but no weight loss, and these patches lack FDA approval. Separately, industry experts are debating the future of middle management amid the rise of artificial intelligence. They suggest AI is not making all managers obsolete, but specifically those whose primary value was controlling information flow within organizations.